Doses - HYDROCODONE BITARTRATE

Dogs:

a) 2.5 - 10 mg (hydrocodone) PO q6-12h, not to exceed 0.5 - 1.0 mg/kg (Roudebush1985)
b) For collapsing trachea: 0.25 mg/kg PO bid-qid (Prueter 1988b)
c) For adjunctive treatment of bacterial bronchitis: 0.22 mg/kg PO bid-qid (Bauer 1988)
d) For persistent, dry, hacking cough in canine upper respiratory infection complex: 0.22mg/kg PO bid-qid (Allen 1988)
Monitoring Parameters - Clinical efficacy and adverse effects
Dosage Forms/Preparations/FDA Approval Status/Withholding Times - Veterinary-Approved Products: None

Human-Approved Products:

Hydrocodone is available commercially only in combination products approved for human use. Hydrocodone Bitartrate 5 mg, Homatropine MBr 1.5 mg Tablets; Hycodan® Tablets (Du Pont);
Tussigon® Tablets (Daniels); (Rx)
Hydrocodone Bitartrate 5 mg, Homatropine MBr 1.5 mg (per 5 ml) Oral Liquid; in pints and gallons; Hycodan® Syrup (Du Pont); Hydropane® Syrup (Halsey); Mycodone® Syrup (My-K); Codan® Syrup (Warner Chilcott); Hydrotropine® Syrup (Rugby); Generic Hydrocodone Syrup; (Rx)
The products listed above are the ones most commonly used in small animal medicine. Other oral tablets and liquids with hydrocodone are available in combination with decongestants (pseudoephedrine, phenylephrine, or phenylpropanolamine), antihistamines (chlorpheniramine), analgesics (acetominophen or aspirin) or expectorants (guaifenesin). All commercially availableproducts containing hydrocodone are Class-III controlled substances.